Germany's Merck tweaks mid-term healthcare unit guidance
Reuters·2025-10-16 05:04
Core Insights - Merck KGaA has slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day [1] Company Summary - The company is a German pharmaceuticals and technology firm [1] - The update in guidance indicates a positive outlook for the healthcare segment [1]